ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

6 links0 made here, not in the record6 judgments3 judges (the rules as one: Rule based)0 record changes seen
GPT-6.1 Sol (High)Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05263050Trial of an AlternativeCabozantinib DosingSchedule in MetastaticRenal Cell Carcinoma andNeuroendocrine TumorsFox Chase Cancer CenterPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSCarcinoma, Renal CellThe registry's MeSH filing›Oct 20 · GPT-6.1 Sol (High) · Broader: NeoplasmsBroader: NeoplasmsClear-cell metastatic renal…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionNeuroendocrine TumorsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Carcinoid TumorThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSCabozantinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · establishedNov 18 · Rule based · BackgroundBackground · established

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Carcinoma, Renal Cell

From the registry record1 judgment on this link
Fit of the first condition term, from the registry to what was judged
RegistryCarcinoma, Renal Cell, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Oct 20Carcinoma, Renal CellGPT-6.1 Sol (High)Broader: NeoplasmsCurrent
Nov 2CabozantinibClaude Opus 5.5TestedCurrent
Nov 2NivolumabClaude Opus 5.5Background · establishedCurrent
Nov 18CabozantinibRule based · role ruleTestedAgrees
Nov 18NivolumabRule based · role ruleBackgroundAgrees
As of nowClear-cell metastatic renal cell carcinomaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.